06/03/2019 00:17:38

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Acorda Therapeutics, Inc. Investors (ACOR)

LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) --

Glancy Prongay & Murray LLP (“GPM”) announces its investigation on behalf of Acorda Therapeutics, Inc. (NASDAQ: ACOR) investors concerning the Company and its directors’ and officers’ possible violations of state laws.

If you purchased Acorda Therapeutics stock, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, CA 90067 at 310-201-9150, Toll-Free at 888-773-9244 or Garth Spencer, of GPM, 230 Park Avenue, Suite 530, New York, NY 10169 at gspencer@glancylaw.com or at 212-682-5340. If you inquire by email please include your mailing address, telephone number, and the number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Glancy Prongay & Murray LLP

Lesley Portnoy, 310-201-9150 or 888-773-9224

Garth Spencer, 212-682-5340

gspencer@glancylaw.com

www.glancylaw.com

GPM Logo.jpg

Del

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
17 Sep
CHEMM
Mullen jeg tror du hænger meget fast i hvordan markedet så ud for ½ år tilbage. Vi har i mellemtiden..
38
18 Sep
DANSKE
Her er lidt om de Berlingske løgnhistorier o Danske Bank - for det tilfælde I har lyst til at anlægg..
29
17 Sep
 
Kære EI,   Jeg har stor forståelse for at i skal tjene penge, for at kunne ove ville udbyde de ydels..
23
22 Sep
OMXC25
Har scannet C25 aktierne igennem og fundet nogle ting som jeg vil være på udkig efter den kommende t..
20
18 Sep
DANSKE
Hvor er dog dejligt at der er en journalist der går lidt dybere og ser hvad journalistik kan bruges ..
16
00:58
VELO
Velkommen til ugens faste tråd om Veloxis & Envarsus 😊   Intet nyt. Vi venter nok alle på afslutni..
14
19 Sep
DANSKE
ref 417838   Det er jo bare endnu en ubegavet journalist fra Berlingeren, der ikke ved en dyt om, Ja..
13
20 Sep
VWS
Mon ikke lige vi skal spise brød til, inden vi konkluderer af GE løber med sejren. De har end ikke d..
12
21 Sep
 
Håber dette er okay for admin Nordnet og deres fusk - meld dig ind og fortæl din historie Det..
11
18 Sep
DANSKE
INVESTOR1 : Jeg tror blot vi aktionærer i Danske Bank, er lidt mere vel afbalanceret som helhed. Vi ..
11

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

#

EuroInvestor: In Focus
#

Most read news

  • 24 hours
  • 48 hours
  • 1 week
1
Oncology Venture presents positive data at ESMO on DRP as   a response predictor for 5-FU treatment in colorectal cancer
2
BeiGene Announces Clinical Results on Tislelizumab Presented at the 22nd Annual Meeting of the Chinese Society of Clinical Oncology (CSCO)
3
Finisar Presents Industry-First Optical Communication Solutions Driving Next-Generation Data Centers and Carrier Networks at ECOC 2019
4
Youth INC and RBC Gather Thousands to Raise $1.7 Million for New York City Youth
5
5-DAY DEADLINE ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against 3M Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

Latest news


Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
23 September 2019 13:01:37
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190829.2 - EUROWEB1 - 2019-09-23 14:01:37 - 2019-09-23 13:01:37 - 1000 - Website: OKAY